{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-036573","form_type":"8-K","ticker":"INBP","cik":"0001016504","company_name":"INTEGRATED BIOPHARMA INC","filed_at":"2025-12-01T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.544580+00:00","generated_at":"2026-05-16T15:49:41.773210+00:00","sec_items":["5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Shareholders re-elect director, approve 3-year say-on-pay frequency, ratify auditor","bullets":["Eric Friedman re-elected as Class III director with 20.66M votes for, 183k withheld, and 1.81M broker non-votes.","Non-binding advisory vote: 20.40M shares favor 3-year frequency for executive compensation votes.","Executive compensation say-on-pay approved: 20.79M for, 56,978 against, 700 abstain.","Ratification of CBIZ CPAs P.C. as independent auditors for FY2026: 22.54M for, 113k against, 1,138 abstain."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-036573","json":"https://secwatch.observer/filing/0001437749-25-036573.json","markdown":"https://secwatch.observer/filing/0001437749-25-036573.md","text":"https://secwatch.observer/filing/0001437749-25-036573.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1016504/000143774925036573/0001437749-25-036573-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1016504/000143774925036573/inbp20251201_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T15:49:41.773210+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}